Renaissance BioScience Corp. and Timeless Capital Corp. Announce Definitive Agreement and TSXV Conditional Approval of Transaction
CALGARY, AB — Timeless Capital Corp. (“Timeless”) (TSXV: TLC.P) and Renaissance BioScience Corp. (“Renaissance”) are pleased to announce that they have entered into an amalgamation agreement dated April 5, 2023 (the… Read More


